Peptide News Digest

#Peptide-Wellness

2 stories

Industry · View digest

The Precision Peptide Company + MMA Group Strategic Marketing Partnership (May 8): Peptide Distribution Across 800-Gym Network

The Precision Peptide Company (BPC) announced a strategic exclusive marketing partnership on May 8 with Mixed Martial Arts Group Limited (MMA), covering distribution of BPC's peptide product line through MMA's network of approximately 530,000 user profiles, 75,000 active students, and 800 verified gyms globally. The revenue-sharing arrangement splits net revenue 50/50 between the two companies for the first 12 months, then shifts to 75% BPC / 25% MMA for the remainder of the term. The deal taps into the broader consumer peptide wellness market projected to approach $300B (per the May 12 GlobeNewswire industry report) and signals the increasingly mainstream integration of peptide products into the combat-sports and broader athletic-performance distribution channels ahead of the July 23-24 PCAC meeting.

Industry · View digest

Peptide Wellness Market Could Approach $300 Billion as Consumer Demand Accelerates Ahead of July PCAC (May 12 GlobeNewswire)

A May 12 GlobeNewswire industry report frames the consumer peptide wellness market as approaching $300B globally on accelerating mainstream demand for science-backed peptide products spanning energy, recovery, metabolism, healthy aging, fitness, and overall well-being. The report tracks the post-Category-2 commercial cycle for BPC-157, TB-500, GHK-Cu, sermorelin, and the broader peptide supplement and cosmeceutical landscape — including OMI Wellbeauty's hair-growth peptides, Neurogan's 2% GHK-Cu body care, Auro Wellness's copper tripeptide serum, and the early-stage longevity peptide programs at Hims & Hers and LifeMD. The framing arrives six weeks ahead of the FDA's PCAC July 23-24 meeting that will decide compounding-pharmacy status for seven additional peptides including Emideltide (DSIP), Semax, and Epitalon.